# Belatacept Therapy for the Failing Renal Allograft

> **NCT01921218** · PHASE3 · COMPLETED · sponsor: **Andrew B Adams** · enrollment: 13 (actual)

## Conditions studied

- Failing Renal Allograft

## Interventions

- **DRUG:** Belatacept
- **DRUG:** Calcineurin inhibitor therapy
- **DRUG:** Mycophenolate mofetil
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT01921218
- **Lead sponsor:** Andrew B Adams
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2019-12-12
- **Final completion:** 2019-12-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921218, "Belatacept Therapy for the Failing Renal Allograft". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01921218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*